EAM Investors’s DexCom DXCM Stock Holding History

EAM Investors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-182,556	Closed	-$2.51M	–	347
2014 Q4	$2.51M	Buy	182,556 +45,556	+33%	+$558K	0.35%	116
2014 Q3	$1.37M	Sell	137,000 -6,884	-5%	-$70.4K	0.28%	157
2014 Q2	$1.43M	Buy	143,884 +8,600	+6%	+$76.2K	0.27%	167
2014 Q1	$1.4M	Sell	135,284 -9,972	-7%	-$103K	0.25%	185
2013 Q4	$1.29M	Sell	145,256 -6,432	-4%	-$50.9K	0.23%	222
2013 Q3	$1.07M	Sell	151,688 -50,160	-25%	-$318K	0.21%	243
2013 Q2	$1.13M	Buy	+201,848	New	+$967K	0.25%	166

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EAM Investors's DXCM Position: Q1 2015 in Review

EAM Investors sold out of DexCom (DXCM) in Q1 2015, closing a stake of 182,556 shares — an estimated $2.51M sold.

EAM Investors first reported a position in DXCM in Q2 2013 and held it in 7 quarters. The position peaked at $2.51M in Q4 2014. 245 funds tracked by Wall St. Rank hold DXCM as of Q1 2015.

EAM Investors reported no remaining DexCom position as of Q1 2015 after selling out during the quarter.
EAM Investors sold 182,556 DexCom shares in Q1 2015, an estimated $2.51M.
EAM Investors first reported a position in DexCom in Q2 2013 and held it in 7 quarters.
EAM Investors's DexCom position peaked at $2.51M in Q4 2014.
245 funds tracked by Wall St. Rank held DexCom as of Q1 2015.

Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.